ライフサイエンスコーパス: preterm delivery

1 of these babies dying as a direct result of preterm delivery.

2 ly associated with fetal mortality and early preterm delivery.

3 is in pregnant persons at increased risk for preterm delivery.

4 m in the index pregnancy or had a history of preterm delivery.

5 ty, was associated with an increased risk of preterm delivery.

6 but was inconclusive for women with a prior preterm delivery.

7 ith the recognition of brain injuries due to preterm delivery.

8 the expression of inflammatory mediators and preterm delivery.

9 l secretions has been used as a predictor of preterm delivery.

10 ity-related risks were highest for extremely preterm delivery.

11 ks of preterm delivery, especially extremely preterm delivery.

12 age was associated with an increased risk of preterm delivery.

13 preeclampsia, cesarean section delivery, and preterm delivery.

14 whether AS intake is indeed associated with preterm delivery.

15 ages is associated with an increased risk of preterm delivery.

16 complicated pregnancies requiring emergency preterm delivery.

17 n on perinatal mortality is mediated through preterm delivery.

18 sma parvum serovar 3 either 7 or 70 d before preterm delivery.

19 , this was not significantly associated with preterm delivery.

20 therapy for women presenting with threatened preterm delivery.

21 ty, as measured by apparent temperature, and preterm delivery.

22 ons responsible for impaired development and preterm delivery.

23 rm delivery has no net benefit in preventing preterm delivery.

24 n pregnancy are at high risk for spontaneous preterm delivery.

25 sions in medically indicated and spontaneous preterm delivery.

26 e presence of the organism may contribute to preterm delivery.

27 the maternal-placental interface in cases of preterm delivery.

28 contributes to increased risk of spontaneous preterm delivery.

29 ed small-for-gestational age (SGA) birth and preterm delivery.

30 vaginosis in pregnant women at high risk for preterm delivery.

31 in a mouse model of inflammation-associated preterm delivery.

32 how to classify disorders that lead to such preterm delivery.

33 vaginosis in pregnant women at low risk for preterm delivery.

34 echanism of pregnancy complications, such as preterm delivery.

35 cy are associated with an increased risk for preterm delivery.

36 ere used to test for effects of treatment on preterm delivery.

37 oint (95% CI 1.07 to 3.24) increased risk of preterm delivery.

38 nd biochemical abnormalities associated with preterm delivery.

39 n pregnant persons not at increased risk for preterm delivery.

40 int (95% CI -1.26 to 4.38) increased risk of preterm delivery.

41 ng a subset of patients at increased risk of preterm delivery.

42 and cervical shortening in women at risk of preterm delivery.

43 -A may be an effective strategy for delaying preterm delivery.

44 s) used during pregnancy on fetal growth and preterm delivery.

45 on during pregnancy may be a risk factor for preterm delivery.

46 The associations are similar for the risk of preterm delivery.

47 placental insufficiency against the risks of preterm delivery.

48 l pessary can reduce the risk of spontaneous preterm delivery.

49 nancy complications such as miscarriages and preterm delivery.

50 is a major factor that predisposes women to preterm delivery.

51 ; its failure is associated with abortion or preterm delivery.

52 cted pregnant women and were associated with preterm delivery.

53 nancy and to evaluate their association with preterm delivery.

54 activity was increased in human amnion from preterm deliveries.

55 o assess coverage for these interventions in preterm deliveries.

56 2%, 95% CI -8.28, -0.60, p = 0.024), overall preterm delivery (-11.72%, 95% CI -15.87, -7.35, p<0.001

57 n pregnancy (n = 669) had increased risks of preterm delivery (164/664; 25% versus 144/2200; 6.5%; ad

58 60), any major birth defect (1233 vs. 4932), preterm delivery (1792 vs. 7168), and birth of infants a

59 elivery (360 [35.4%]), preterm labor without preterm delivery (269 [26.4%]), and miscarriage (262 [25

60 The 3 most frequent adverse events were preterm delivery (360 [35.4%]), preterm labor without pr

61 Forty women had preterm delivery, 39 women delivered a low-birth-weight

62 nd 120% increased odds), and reduced odds of preterm delivery (50% and 60% decreased odds).

63 (hazard ratio, 1.64; 95% CI, 1.42 to 1.88); preterm delivery, 53.3% vs. 17.8% (hazard ratio, 4.68; 9

64 nce odds ratio, 1.12; 95% CI, 0.69 to 1.82), preterm delivery (6.2% and 5.2%; prevalence odds ratio,

65 ata show a 3.8-fold reduction in the rate of preterm delivery, a decrease in periodontal pathogen loa

66 idemiologists can use recurrence patterns of preterm delivery across generations to assess the relati

67 as also associated with an increased risk of preterm delivery (adjusted OR: 1.25; 95% CI: 1.08, 1.45)

68 xtent that unmeasured pathologies triggering preterm delivery also directly harm the fetus, they will

69 There were 19 (7%) preterm deliveries among the 268 subjects.

70 ved between first trimester sCD14 levels and preterm delivery among HIV-infected women.

71 The increased risk of preterm delivery among mothers born preterm is consisten

72 ociated with the risk of low birth weight or preterm delivery among mothers who have had at least 2 l

73 been born preterm and calculated the risk of preterm delivery among their firstborn.

74 Improved management of preterm deliveries and improved collection, processing,

75 Treatment with (+)-naltrexone prevented preterm delivery and alleviated fetal demise in utero el

76 Treatment with (+)-naloxone prevented preterm delivery and alleviated fetal demise in utero el

77 We compared preterm delivery and birth weight (BW) outcomes (low BW

78 een smoking and preeclampsia with respect to preterm delivery and birth weight; smokers who developed

79 nal abnormalities, structural abnormalities, preterm delivery and death.

80 ts during pregnancy protect newborns against preterm delivery and early neonatal death, but the impac

81 Severity was associated with preterm delivery and fetal loss.

82 acts via TLR2 to suppress TLR ligand-induced preterm delivery and inflammatory responses.

83 egnancy complications, including spontaneous preterm delivery and preeclampsia.

84 hood and adulthood neighborhood privilege on preterm delivery and related disparities.

85 e suggests no difference in the incidence of preterm delivery and related outcomes from treatment for

86 at the Extremes (ICE), were associated with preterm delivery and related racial/ethnic disparities u

87 Reductions were observed in the risk of preterm delivery and small for gestational age 3 mo prio

88 determine the impact of this legislation on preterm delivery and small for gestational age.

89 iated with adverse birth outcomes, including preterm delivery and small-for-gestational-age (SGA) bir

90 Severe disease is complicated by spontaneous preterm delivery and stillbirth.

91 The prevalence of preterm delivery and the correlation between gestational

92 ery was associated with an increased risk of preterm delivery and uterine dehiscence at delivery.

93 eous abortion, intrauterine-fetal-death, and preterm delivery) and neonatal sequelae [small for gesta

94 orn saliva, intrauterine growth restriction, preterm deliveries, and controls.

95 GH vs no HDP, 1.62 (95% CI, 1.46-1.79) after preterm delivery, and 1.86 (95% CI, 1.15-3.02) after sti

96 14) for Q3, and 8.86 (5.66-13.86) for Q4 for preterm delivery, and 2.29 (95% CI 1.08-4.84) for Q2, 3.

97 o developed preeclampsia had a lower risk of preterm delivery, and a lower adjusted mean difference i

98 neighborhood with high firearm violence and preterm delivery, and assessed whether there was mediati

99 30 kg/m(2) or higher, obstetric hemorrhage, preterm delivery, and caesarean section (ARs, >/=637/100

100 eriod, no maternal smoking during pregnancy, preterm delivery, and congenital malformations.

101 ing outcomes were studied: cesarean section, preterm delivery, and early preterm delivery; small for

102 e birth outcomes (small for gestational age, preterm delivery, and low birth weight) were evaluated.

103 Cox regression was used for preterm delivery, and Poisson regression for other outco

104 llitus, hypertensive disorders of pregnancy, preterm delivery, and size for gestational age with calc

105 r hemorrhagic stroke, and oophorectomy, HDP, preterm delivery, and stillbirth for any stroke.

106 , including intrauterine growth restriction, preterm delivery, and stillbirth.

107 In pregnancy it may cause fetal loss or a preterm delivery, and the neonate is prone to neonatal s

108 Firearm violence was associated with risk of preterm delivery, and this association was partially med

109 stillbirth (aPR, 1.6 [95% CI, 1.1-2.4]), and preterm delivery (aPR, 1.6 [95% CI, 1.4-1.8]).

110 Current therapeutic approaches to preterm delivery are ineffective and present serious ris

111 tween overweight and obesity and subtypes of preterm delivery are not clear.

112 more large-scale studies of temperature and preterm delivery are warranted.

113 e found significant elevated risks of having preterm delivery as RR = 3.08, 95% confidence interval (

114 esity are associated with increased risks of preterm delivery, asphyxia-related neonatal complication

115 iteria, and race/ethnicity influence the HCA-preterm delivery association and that HCA contributes to

116 rticosteroids, in spontaneous, uncomplicated preterm deliveries at 26-34 weeks' gestation.

117 Spontaneous preterm delivery at <35 weeks was significantly associat

118 istic regression models, medically indicated preterm delivery at <35 weeks was significantly associat

119 actors varied between incident and recurrent preterm delivery at <37 weeks.

120 s C.albicans or saline at 3 or 5 days before preterm delivery at 122 days of gestation.

121 7 days (2- and 7-day repeat exposure) before preterm delivery at 124 days gestation (term=150 days).

122 Spontaneous preterm delivery at 35-36 weeks was significantly associ

123 Among preterm deliveries before 35 weeks excluding those medic

124 gher rates than zidovudine-based ART of very preterm delivery before 34 weeks (6.0% vs. 2.6%, P=0.04)

125 n African Americans, HCA was associated with preterm delivery before 35 weeks.

126 zidovudine alone (16.9% vs. 8.9%, P=0.004); preterm delivery before 37 weeks was more frequent with

127 gestation resulted in a reduced incidence of preterm delivery before 37 weeks, and reduced perinatal

128 grouped the multiple disorders that lead to preterm delivery before the 28th week of gestation in a

129 n models to identify factors associated with preterm delivery (before 37 weeks' gestation) and small

130 ssessed 112 women with at least one previous preterm delivery between 16 and 34 weeks' gestation.

131 ts indicate that fFN is not only a marker of preterm delivery but also plays a significant role in th

132 ated fatty acids may reduce the incidence of preterm delivery but may also prolong gestation beyond t

133 PI-based HAART was associated with increased preterm delivery but not increased infant hospitalizatio

134 ratures with adverse birth outcomes, such as preterm delivery, but other birth outcomes have not been

135 Obesity increases the risk of preterm delivery, but the associations between overweigh

136 GSI treatment prevents PGN+poly(I:C)-induced preterm delivery by 55.5% and increased the number of li

137 timated SGA birth by 12.9% and overestimated preterm delivery by 8.7%.

138 ath/stillbirth, poor fetal growth, abortion, preterm delivery, C-section, obstetric bleeding, infecti

139 upture of membranes) and medically indicated preterm delivery (cesarean delivery before onset of labo

140 tes of antenatal corticosteroid use, induced preterm deliveries, cesarean deliveries, and surfactant

141 asone administered to women at risk for late preterm delivery decreases the risks of neonatal morbidi

142 The primary outcome was early preterm delivery, defined as delivery before 34 complete

143 o magnesium sulfate before anticipated early preterm delivery did not reduce the combined risk of mod

144 otective role in preventing inflammation and preterm delivery during pregnancy.

145 with adverse obstetrical outcomes including preterm delivery, early miscarriage, postpartum endometr

146 h the lowest quartile set as reference) with preterm delivery, early-term delivery, low birthweight,

147 ancy were associated with increased risks of preterm delivery, especially extremely preterm delivery.

148 y 31 operations associated with 1 additional preterm delivery, every 39 operations associated with 1

149 Risks of preterm deliveries (extremely, 22-27 weeks; very, 28-31

150 otency with mode of delivery, birth defects, preterm delivery, fetal death, and low Apgar score.

151 Orofacial cleft, low birth weight, preterm delivery, fetal death, low Apgar score, and mode

152 sure with orofacial cleft, low birth weight, preterm delivery, fetal death, low Apgar score, and mode

153 orticosteroid exposure with orofacial cleft, preterm delivery, fetal death, low Apgar score, and mode

154 reporting findings among women with a prior preterm delivery, findings were inconsistent; 3 showed a

155 The difference concerned mainly induced preterm delivery for maternal or fetal indications (5.6%

156 nt associations for apparent temperature and preterm delivery found in this study, more large-scale s

157 Using a mouse model of infection-induced preterm delivery, gestational tissues were collected 8 h

158 Preterm delivery has been shown to be associated with in

159 feine intake during pregnancy on the risk of preterm delivery has been studied for the past 3 decades

160 n pregnant persons not at increased risk for preterm delivery has no net benefit in preventing preter

161 Risk factors for preterm delivery have been described, but whether risk f

162 Associations between stress hormones and preterm delivery have not been fully explored.

163 ccreta spectrum (PAS), increases the risk of preterm delivery, hemorrhage, and death.

164 Prior preterm delivery history is important when assessing sub

165 risk factors differ in the context of prior preterm delivery history is less understood.

166 are used to treat pregnant women at risk for preterm delivery; however, prenatal exposure to GCs may

167 h MS had an increased risk of infections and preterm delivery; however, their risks for other adverse

168 (May 2002-June 2005) of Iowa SGA births and preterm deliveries identified from birth records (n = 2,

169 T) use in pregnancy has been associated with preterm deliveries in some observational studies.

170 ions between placental vascular findings and preterm delivery in 1,053 subcohort women (239 preterm,

171 cient (ADC) of the cervix is associated with preterm delivery in asymptomatic patients with a sonogra

172 -income + race/ethnicity was associated with preterm delivery in both early childhood (relative risk

173 2 was positively associated with spontaneous preterm delivery in NYC.

174 nsive ablation does not decrease any risk of preterm delivery in subsequent pregnancies.

175 prepregnancy lifestyle and CVD risk factors, preterm delivery in the first pregnancy was associated w

176 nancy factors were associated with recurrent preterm delivery, including alcohol, thyroid disease, an

177 Risks of medically indicated preterm deliveries increased with BMI among overweight a

178 Risks of extremely, very, and moderately preterm deliveries increased with BMI and the overweight

179 Risk of spontaneous extremely preterm delivery increased with BMI among obese women (B

180 Although preterm delivery is a major global health issue, its cau

181 Preterm delivery is a powerful predictor of newborn morb

182 positive pregnant women an increased rate of preterm delivery is associated with highly active antire

183 Concordance for preterm delivery is elevated in monozygotic compared wit

184 Preterm delivery is independently predictive of CVD and

185 The chorioamnionitis associated with preterm delivery is often polymicrobial with ureaplasma

186 differences in maternal anemia, stillbirths, preterm delivery, LBW, or all-cause mortality of infants

187 ternal DNA in cord blood was associated with preterm delivery, low birth weight, and maternal immunos

188 atory nicotine inhalation is associated with preterm delivery, low birth weight, fetal growth retarda

189 e, race or ethnic origin, pre-pregnancy BMI, preterm delivery, low birthweight, maternal antibiotic u

190 percentile, preterm delivery <37 weeks, and preterm delivery <34 weeks with minimal heterogeneity.

191 sits to determine the relationship to cases (preterm delivery <37 weeks' gestation) and controls (ter

192 , SGA <10th percentile, SGA <5th percentile, preterm delivery <37 weeks, and preterm delivery <34 wee

193 st partum; 0.86 [0.74-1.00], p=0.039), early preterm delivery (<34 weeks; 0.75 [0.61-0.93], p=0.039),

194 the use of a sonic toothbrush on the rate of preterm delivery (<37 weeks gestation).

195 he risk of having adverse neonatal outcomes: preterm delivery (<37 weeks of gestation), low birth wei

196 wn neonatal death up to 7 days after birth), preterm delivery (<37 weeks' gestation), or neonatal uni

197 Risk factors for preterm delivery (<37 weeks) and differences by randomiz

198 ight (in grams), low birth weight (<2500 g), preterm delivery (<37 weeks), small for gestational age

199 o estimate the pooled effect of treatment on preterm delivery (<37 weeks, <34 weeks, or <32 weeks) an

200 o estimate the pooled effect of treatment on preterm delivery (<37, <34, and <32 weeks); low birthwei

201 es, such as preeclampsia, cesarean delivery, preterm delivery, macrosomia, and congenital defects.

202 In the setting of a prior preterm delivery, many risk factors did not persist.

203 Sensitivity, specificity, preterm delivery, maternal adverse effects, congenital b

204 Disorders leading to preterm delivery may be separated into two groups: those

205 nfants of pregnant women at risk of imminent preterm delivery may benefit from its use.

206 Risks of preterm delivery, meconium-stained amniotic fluid, and s

207 k ratios of the natural direct and indirect (preterm delivery-mediated) effects of abruption on morta

208 In a mouse inflammation-induced preterm delivery model, intrauterine administration of S

209 , SGA); and "severe" combined outcome (early preterm delivery, NICU, SGA).

210 CKD stage shift; "general" combined outcome (preterm delivery, NICU, SGA); and "severe" combined outc

211 type of antiretroviral therapy were sought: preterm delivery occurred in 14.2% of the 211 deliveries

212 curred in 4%, neonatal death occurred in 1%, preterm delivery occurred in 9%, and SGA neonate occurre

213 Early preterm delivery occurred in the case of 61 of 2734 preg

214 ART was the most significant risk factor for preterm delivery [odds ratio = 2.03, 95% confidence inte

215 Mothers born preterm had a relative risk for preterm delivery of 1.54 (95% confidence interval (CI):

216 e of increasing indicated preterm births and preterm delivery of artificially conceived multiple preg

217 sting a mechanism for the adverse effects of preterm delivery on cognitive function.

218 did not result in a lower incidence of early preterm delivery or a higher incidence of interventions

219 ated hypertension and diabetes, as well as a preterm delivery or a low birth weight delivery, to exce

220 association between maternal PHIV status and preterm delivery or infant BW outcomes is reassuring.

221 ngthened after excluding medically indicated preterm deliveries (OR = 4.9, 95% CI: 2.0, 11.8); and st

222 ntly decreased incidence odds ratio (OR) for preterm delivery (OR = 0.26; 95% confidence interval = 0

223 the lowest quartile had an increased risk of preterm delivery (OR: 1.72; 95% CI: 1.14, 2.60) and chil

224 ous abortion, low birth weight in an infant, preterm delivery, or congenital anomalies in an infant)

225 te birth outcome (small for gestational age, preterm delivery, or low birth weight).

226 It is associated with an increased risk of preterm delivery, pelvic inflammatory disease, and an in

227 identified as an independent risk factor for preterm delivery, perinatal mortality, and other complic

228 ncy outcomes (infections, cesarean delivery, preterm delivery, poor fetal growth, preeclampsia, chori

229 The remainder were complicated by preterm delivery, preeclampsia, and/or small-for-gestati

230 aternal particulate matter (PM) exposure and preterm delivery (PTD) by folic acid (FA) supplementatio

231 Outcomes included stillbirths (SBs), preterm delivery (PTD), small for gestational age (SGA),

232 sidential environment may be associated with preterm delivery (PTD), though few studies exist.

233 plants and adverse birth outcomes including preterm delivery (PTD), very preterm delivery (VPTD), an

234 es treatment during pregnancy in relation to preterm delivery (PTD), we conducted a multicenter, memb

235 nsistently associated with increased risk of preterm delivery (PTD).

236 tis (HCA), a condition linked to spontaneous preterm delivery (PTD).

237 uption and excess thrombin generation elicit preterm delivery (PTD).

238 Inflammation is frequently linked to preterm delivery (PTD).

239 rupture of the membranes (PPROM) as well as preterm delivery (PTD).

240 ng malaria are related to pregnancy loss and preterm delivery (PTD).

241 inhibitor associated with increased risk of preterm delivery (range, 14.4%-26.1%).

242 ies which factors explain the differences in preterm delivery rates and potentially the association o

243 Cesarean delivery and preterm delivery rates did not differ.

244 Preterm delivery rates were higher among 267 women in th

245 n to pregnant women at imminent risk of very preterm delivery reduces the risk of cerebral palsy in e

246 very association and that HCA contributes to preterm delivery-related ethnic disparity.

247 of BV and to reduce serious sequelae such as preterm delivery, remains an acknowledged but unresolved

248 : 0.67, 1.43; Pinteraction = 0.02 and <0.01) preterm delivery, respectively.

249 Preterm delivery results in adverse outcomes; identifyin

250 story is important when assessing subsequent preterm delivery risk factors.

251 onfer protection from known second pregnancy preterm delivery risk factors.

252 ), stillbirth (RR, 3.94; 95% CI, 2.60-5.96), preterm delivery (RR, 2.21; 95% CI, 1.47-3.31), and smal

253 ear dose-response relationships with risk of preterm delivery (S-shaped, p<0.0001) and low birthweigh

254 ssociations between maternal PHIV status and preterm delivery, SGA, or LBW were observed.

255 Assessment of any effect on preterm delivery should be included in future maternal G

256 fetal growth and cautious decision making on preterm delivery should therefore be reinforced.

257 n of betamethasone to women at risk for late preterm delivery significantly reduced the rate of neona

258 rst born, maternal smoking during pregnancy, preterm delivery, small weight for gestational age, cesa

259 ed: maternal and fetal death; malformations; preterm delivery; small for gestational age (SGA) baby;

260 esarean section, preterm delivery, and early preterm delivery; small for gestational age (SGA); need

261 s between each preterm risk factor and prior preterm delivery status to explore whether risk factors

262 The main outcome measures investigated were preterm delivery, stillbirth, and neonatal unit admissio

263 utcome variable (i.e., term (referent) and 3 preterm delivery subtypes: spontaneous; premature ruptur

264 e sensitivity of this algorithm is lower for preterm deliveries, suggesting limited validity to asses

265 ministration of SP-A significantly inhibited preterm delivery, suppressed the expression of proinflam

266 result in a lower rate of spontaneous early preterm delivery than the rate with expectant management

267 black and Hispanic women had higher risk of preterm delivery than white women (RR = 1.32, 95% CI: 1.

268 ent (Camp(-/-)) mice are less susceptible to preterm delivery than wild type mice following intrauter

269 t for pregnant persons at increased risk for preterm delivery, the evidence is conflicting and insuff

270 infection is considered as a risk factor for preterm delivery, the localization of oral bacteria or t

271 h intake of AS beverages was associated with preterm delivery; the adjusted OR for those drinking >1

272 5% confidence interval (CI): 1.16, 1.27) and preterm delivery (Truven Health: aRR = 1.19 (95% CI: 1.0

273 different in women with versus without prior preterm delivery using medical records of the first and

274 comes including preterm delivery (PTD), very preterm delivery (VPTD), and term low birth weight (LBW)

275 In the LTx and RTx groups, the percentage of preterm deliveries was 48.8% (68.8% in the RTx and 43.2%

276 The rate of preterm deliveries was higher in the lithium group compa

277 women (BMI 18.5-<25), the rate of extremely preterm delivery was 0.17%.

278 of increased mortality risk mediated through preterm delivery was 28.1%, with even higher proportions

279 e was 6%, large for gestational age was 14%, preterm delivery was 7%, substantial postpartum weight r

280 ease (95% confidence interval: 6.0, 11.3) in preterm delivery was associated with a 10 degrees F (5.6

281 In women with stage 1 CKD, preterm delivery was associated with baseline hypertensi

282 Preterm delivery was associated with maternal asthma for

283 Preterm delivery was associated with maternal drug-treat

284 sm on parasite density, low birth weight, or preterm delivery was discernible.

285 The risk of spontaneous preterm delivery was increased in the highest versus low

286 variate analysis, risk for preterm and early-preterm delivery was linked to CKD stage (2-5 vs 1: rela

287 Preterm delivery was seen in 780 (9%, 95% CI 8-9) of 886

288 When preterm delivery was split into moderate preterm (>/=32

289 Preterm delivery was the primary outcome, and data were

290 adverse birth outcomes: crude estimates for preterm delivery were 6.3% of vaccinated and 7.8% of unv

291 Cases of preterm delivery were also included.

292 ted odds ratios (ORs [95% CIs]) of extremely preterm delivery were as follows: BMI 25 to less than 30

293 tions, whereas small for gestational age and preterm delivery were associated with higher blood press

294 sociations between each cytokine and SGA and preterm delivery were evaluated using log binomial regre

295 Factors associated with preterm delivery were history of injecting drug use (adj

296 Gestational age and preterm delivery were statistically significantly associ

297 ypothesis that a woman is at greater risk of preterm delivery when she has had elevated exposure to a

298 ot recurrent (RR = 1.09, 95% CI: 0.71, 1.19) preterm delivery, whereas alcohol was associated with an

299 57BL/6J mice on embryonic day 14.5 triggered preterm delivery within 24 h.

300 f lipopolysaccharide (LPS) at E17 stimulates preterm delivery within 24 hours.